GNH USA

Europe — EMA

Octanine (Human Coagulation Factor Ix)

GNH USA supplies Octanine (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B and related bleeding disorders.

Human Coagulation Factor Ix

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It replaces deficient factor IX in patients with hemophilia B, helping to control bleeding episodes. GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

What is Human Coagulation Factor Ix used for?

Octanine is used in the management of inherited bleeding disorders that involve factor IX deficiency.

- Hemophilia B: Provides temporary replacement of factor IX to prevent or control bleeding. - Perioperative management: Supplies factor IX to maintain hemostasis during surgery for patients with hemophilia B. - Trauma‑related bleeding: Offers factor IX replacement to manage acute bleeding episodes in individuals with known factor IX deficiency.

What are the side effects of Human Coagulation Factor Ix?

Adverse reactions to Octanine may vary in frequency and severity.

Common Side Effects: - Headache - Fever - Nausea - Injection site erythema - Mild hypotension - Fatigue

Serious or Rare Side Effects: - Anaphylactic reaction - Development of inhibitors (neutralizing antibodies) - Thromboembolic events - Severe hypersensitivity including angioedema - Renal impairment - Hepatotoxicity

What precautions apply to Human Coagulation Factor Ix?

When using Octanine, clinicians should consider several safety measures.

- Dosing adjustments: Tailor dose based on individual pharmacokinetic response and factor IX activity levels. - Inhibitor monitoring: Test periodically for development of factor IX inhibitors. - Surgical planning: Ensure adequate factor IX levels are achieved before invasive procedures. - Pregnancy and lactation: Evaluate risk‑benefit ratio carefully; limited data are available. - Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix interact with?

Octanine may interact with other agents that affect hemostasis.

Major Interactions (Avoid): - Antifibrinolytics such as tranexamic acid combined with high‑dose factor IX may increase thrombotic risk. - Concomitant use of pro‑coagulant agents (e.g., activated factor VII) can lead to excessive clot formation.

Moderate Interactions (Monitor Closely): - Immunosuppressive therapies may influence inhibitor development. - Certain antibiotics (e.g., beta‑lactams) have been reported to cause hypersensitivity when given with protein therapeutics. - Vaccines administered shortly before or after infusion may modestly raise the risk of allergic reactions.

Frequently asked questions

What is Octanine used for?+
Octanine is a recombinant human coagulation factor IX product used to replace deficient factor IX in patients with hemophilia B and to manage bleeding episodes or surgical procedures that require adequate hemostasis.
How does Human Coagulation Factor IX work in Octanine?+
The factor IX in Octanine binds to activated factor X on platelet surfaces, forming the intrinsic tenase complex that accelerates conversion of factor X to factor Xa, thereby restoring thrombin generation and enabling normal clot formation in individuals lacking functional factor IX.
What is the usual dose of Octanine?+
The prescribed dose of Octanine is individualized by the treating physician based on the patient’s weight, severity of factor IX deficiency, bleeding severity, and target factor IX activity levels; exact regimens are not publicly standardized.
Is Octanine safe during pregnancy or breastfeeding?+
Safety data for Octanine in pregnancy and lactation are limited; clinicians should weigh potential benefits against risks and consider alternative management strategies, as factor IX products cross the placenta and may be present in breast milk.
How do I order Octanine from GNH USA?+
To order Octanine, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling) and necessary import documentation.
How does Octanine compare with other factor IX products?+
Octanine is a recombinant factor IX concentrate similar in efficacy to other licensed recombinant products, offering a purified intravenous formulation. Differences among products may include manufacturing processes, specific activity, stability profiles, and approved indications, which clinicians evaluate when selecting therapy.
What are the storage and handling requirements for Octanine?+
Octanine should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, inspect the solution for particulate matter and ensure the vial is within its expiry date.
How is Octanine administered?+
Octanine is given as an intravenous infusion, typically diluted in a compatible solution and administered slowly under clinical supervision, with dosing adjusted according to factor IX activity monitoring.
What are the most serious risks associated with Octanine?+
Serious risks include the development of neutralizing inhibitors against factor IX, severe allergic reactions such as anaphylaxis, and rare thromboembolic events, all of which require immediate medical attention.
Who should not use Octanine?+
Octanine is contraindicated in patients with known hypersensitivity to any component of the product, including the recombinant protein or excipients, and in individuals who have previously developed severe allergic reactions to factor IX concentrates.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU

Related products

Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Aimafix

Aimafix

Human Coagulation Factor Ix

Kedrion S.P.A.
EU
Alphanine

Alphanine

Human Coagulation Factor Ix

Grifols Deutschland Gmbh
EU